Table 3 Cell treatment market size and prospects (unit: 100 million dollars)[24]
From: The market trend analysis and prospects of scaffolds for stem cells
Technology | 2005 | 2010 | 2015 | CAGR |
|---|---|---|---|---|
Stem cells | 20 | 52 | 109 | 18.5% |
Cord blood | 5 | 10 | 23 | 16.5% |
Tissue engineering | 69 | 135 | 232 | 12.9% |
Transfusion products | 128 | 224 | 350 | 10.6% |
Cell-based gene therapy | 15 | 30 | 59 | 14.7% |
Capsule cell treatment | 4 | 19 | 31 | 22.7% |
Cell-based cancer vaccines | 9 | 16 | 29 | 12.4% |
Heteroplastids | 6 | 19 | 32 | 18.2% |
Element technology (Cell lines, cell culture fluid, cell carriers) | 20 | 57 | 98 | 17.2% |
Total | 276 | 562 | 963 | 13.3% |